Location History:
- Cedex, FR (1999)
- Nantes, Cedex, FR (1999)
- Nantes, FR (1998 - 2009)
Company Filing History:
Years Active: 1998-2025
Title: Francine Jotereau: Innovator in Medical Research
Introduction
Francine Jotereau is a prominent inventor based in Nantes, France. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of diseases related to immune system dysfunction. With a total of five patents to her name, her work has the potential to impact the lives of many patients suffering from inflammatory bowel diseases and cancer.
Latest Patents
One of her latest patents focuses on the diagnosis, prognosis, and treatment of diseases associated with a decrease in specific T lymphocytes. This invention involves a method for determining the number, concentration, and proportion of T lymphocytes with a CD4CD8αα phenotype, which express CCR6 and/or CXCR6. This method can be used for diagnosing, prognosing outcomes, or predicting the risk of developing diseases such as inflammatory bowel disease (IBD), including Crohn's disease. Additionally, she has developed peptides derived from the MMP-2 metalloproteinase that form T cell epitopes when presented by MHC Class I molecules, which can be utilized in anti-tumor immunotherapy.
Career Highlights
Throughout her career, Francine has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale) and the University of Nantes. Her research has been pivotal in advancing our understanding of immune responses and developing innovative therapeutic strategies.
Collaborations
Francine has collaborated with notable colleagues, including Yannick Guilloux and Thierry R Boon-Falleur. Their joint efforts have contributed to the success of her research and the development of her patents.
Conclusion
Francine Jotereau's innovative work in medical research exemplifies the impact of dedicated inventors in the field of healthcare. Her contributions to the diagnosis and treatment of immune-related diseases highlight the importance of continued research and innovation in improving patient outcomes.